Page last updated: 2024-09-04

atrasentan and bilirubin

atrasentan has been researched along with bilirubin in 1 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(bilirubin)
Trials
(bilirubin)
Recent Studies (post-2010) (bilirubin)
3584110825,9211,3375,871

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)bilirubin (IC50)
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)3.3884
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.3183

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andress, D; Brennan, JJ; Coll, B; Correa-Rotter, R; Davis, JW; de Zeeuw, D; Heerspink, HJ; Idler, K; Kohan, DE; Liu, M; Makino, H; Parving, HH; Perkovic, V; Remuzzi, G; Tobe, SW; Toto, R1

Trials

1 trial(s) available for atrasentan and bilirubin

ArticleYear
Comparison of exposure response relationship of atrasentan between North American and Asian populations.
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:4

    Topics: Aged; Albuminuria; Asia; Asian People; Atrasentan; Bilirubin; Body Fluids; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Female; Humans; Male; Middle Aged; North America; Pyrrolidines; Treatment Outcome; Weight Gain; White People

2017